Reduced expression of RAS protein activator like-1 in gastric cancer

International Journal of Cancer

Volumn 128, Issue 6, 2011, Pages 1293-1302

  Seto, Motoko ^a   Ohta, Miki ^a   Ikenoue, Tsuneo ^a   Sugimoto, Takafumi ^a   Asaoka, Yoshinari ^a   Tada, Motohisa ^b   Mohri, Dai ^a   Kudo, Yotaro ^a   Ijichi, Hideaki ^a   Tateishi, Keisuke ^a   Otsuka, Motoyuki ^a   Hirata, Yoshihiro ^a   Maeda, Shin ^a   Koike, Kazuhiko ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

gastric tumor; RAS GTPase activating protein; RASAL1

Indexed keywords

GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; HISTONE DEACETYLASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; RAS PROTEIN ACTIVATOR LIKE 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION; GENE LOCUS; GENE SILENCING; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH CARCINOGENESIS;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CELL PROLIFERATION; DISEASE PROGRESSION; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE SILENCING; HUMANS; IMMUNOENZYME TECHNIQUES; LOSS OF HETEROZYGOSITY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUTATION; NEOPLASM INVASIVENESS; PROMOTER REGIONS, GENETIC; RAS GTPASE-ACTIVATING PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 79551497868     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25459     Document Type: Article

References (34)

1. Bar-Sagi D, Hall A,. Ras and Rho GTPases: a family reunion. Cell 2000; 103: 227-38.
2. 2+. FEBS Lett 2003; 546: 6-10.
3. Der CJ, van Dyke T,. Stopping ras in its tracks. Cell 2007; 129: 855-7.
4. Downward J,. Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 2003; 3: 11-22.
5. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M,. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988; 53: 549-54.
6. Tada M, Yokosuka O, Omata M, Ohto M, Isono K,. Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing. Cancer 1990; 66: 930-5. (Pubitemid 20307926)
7. Rajagopalan H, Bardelli A, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE,. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature 2002; 418: 934.
8. Rodenhuis S, van de Wetering ML, Mooi WJ, Evers SG, van Zandwijk N, Bos JL,. Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung. N Engl J Med 1987; 317: 929-35.
9. Bernards A, Settleman J,. GAPs in growth factor signalling. Growth Factors 2005; 23: 143-9.
10. Karnoub AE, Weinberg RA,. Ras oncogenes: split personalities. Nat Rev Mol Cell Biol 2008; 9: 517-31.
11. Skolnick MH, Ponder B, Seizinger B,. Linkage of NF1 to 12 chromosome 17 markers: a summary of eight concurrent reports. Genomics 1987; 1: 382-3.
12. Boon LM, Mulliken JB, Vikkula M,. RASA1: variable phenotype with capillary and arteriovenous malformations. Curr Opin Genet Dev 2005; 15: 265-9.
13. Ohta M, Seto M, Ijichi H, Miyabayashi K, Kudo Y, Mohri D, Asaoka Y, Tada M, Tanaka Y, Ikenoue T, Kanai F, Kawabe T, et al. Decreased expression of the RAS-GTPase activating protein RASAL1 is associated with colorectal tumor progression. Gastroenterology 2009; 136: 206-16.
14. 2+ oscillations. Embo J 2004; 23: 1749-60.
15. 2+. J Cell Biol 2005; 170: 183-90.
16. Kupzig S, Deaconescu D, Bouyoucef D, Walker SA, Liu Q, Polte CL, Daumke O, Ishizaki T, Lockyer PJ, Wittinghofer A, Cullen PJ,. GAP1 family members constitute bifunctional Ras and Rap GTPase-activating proteins. J Biol Chem 2006; 281: 9891-900.
17. Bos JL, Rehmann H, Wittinghofer A,. GEFs and GAPs: critical elements in the control of small G proteins. Cell 2007; 129: 865-77.
18. Tada M, Yokosuka O, Fukai K, Chiba T, Imazeki F, Tokuhisa T, Saisho H,. Hypermethylation of NAD(P)H: quinone oxidoreductase 1 (NQO1) gene in human hepatocellular carcinoma. J Hepatol 2005; 42: 511-9.
19. Tanaka Y, Kanai F, Tada M, Asaoka Y, Guleng B, Jazag A, Ohta M, Ikenoue T, Tateishi K, Obi S, Kawabe T, Yokosuka O, et al. Absence of PIK3CA hotspot mutations in hepatocellular carcinoma in Japanese patients. Oncogene 2006; 25: 2950-2.
20. Kanai F, Marignani PA, Sarbassova D, Yagi R, Hall RA, Donowitz M, Hisaminato A, Fujiwara T, Ito Y, Cantley LC, Yaffe MB,. TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J 2000; 19: 6778-91.
21. Seto M, Ohta M, Asaoka Y, Ikenoue T, Tada M, Miyabayashi K, Mohri D, Tanaka Y, Ijichi H, Tateishi K, Kanai F, Kawabe T, et al. Regulation of the hedgehog signaling by the mitogen-activated protein kinase cascade in gastric cancer. Mol Carcinog 2009; 48: 703-12.
22. Ohta M, Tateishi K, Kanai F, Watabe H, Kondo S, Guleng B, Tanaka Y, Asaoka Y, Jazag A, Imamura J, Ijichi H, Ikenoue T, et al. p53-Independent negative regulation of p21/cyclin-dependent kinase-interacting protein 1 by the sonic hedgehog-glioma-associated oncogene 1 pathway in gastric carcinoma cells. Cancer Res 2005; 65: 10822-9.
23. Jin H, Wang X, Ying J, Wong AH, Cui Y, Srivastava G, Shen ZY, Li EM, Zhang Q, Jin J, Kupzig S, Chan AT, et al. Epigenetic silencing of a Ca(2+)-regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers. Proc Natl Acad Sci USA 2007; 104: 12353-8.
24. Tada M, Kanai F, Tanaka Y, Sanada M, Nannya Y, Tateishi K, Ohta M, Asaoka Y, Seto M, Imazeki F, Yoshida H, Ogawa S, et al. Prognostic significance of genetic alterations detected by high-density single nucleotide polymorphism array in gastric cancer. Cancer Sci 2010; 101: 1261-1269.
25. Kolfschoten IG, van Leeuwen B, Berns K, Mullenders J, Beijersbergen RL, Bernards R, Voorhoeve PM, Agami R,. A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity. Cell 2005; 121: 849-58.
26. Allen M, Chu S, Brill S, Stotler C, Buckler A,. Restricted tissue expression pattern of a novel human rasGAP-related gene and its murine ortholog. Gene 1998; 218: 17-25.
27. Ushijima T, Sasako M,. Focus on gastric cancer. Cancer Cell 2004; 5: 121-5.
28. Shim YH, Kang GH, Ro JY,. Correlation of p16 hypermethylation with p16 protein loss in sporadic gastric carcinomas. Lab Invest 2000; 80: 689-95.
29. Kang GH, Shim YH, Jung HY, Kim WH, Ro JY, Rhyu MG,. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res 2001; 61: 2847-51.
30. Leung SY, Yuen ST, Chung LP, Chu KM, Chan AS, Ho JC,. hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res 1999; 59: 159-64.
31. Fleisher AS, Esteller M, Wang S, Tamura G, Suzuki H, Yin J, Zou TT, Abraham JM, Kong D, Smolinski KN, Shi YQ, Rhyu MG, et al. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res 1999; 59: 1090-5.
32. Machado JC, Oliveira C, Carvalho R, Soares P, Berx G, Caldas C, Seruca R, Carneiro F, Sobrinho-Simoes M,. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene 2001; 20: 1525-8.
33. Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Kim WJ, et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002; 109: 113-24.
34. Chen H, Tu SW, Hsieh JT,. Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer. J Biol Chem 2005; 280: 22437-44.